Sign In
Buy VCYT
$48.69
+0.89 (+1.86%)
At Close: Jun 03, 2026
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
05:15pm, Wednesday, 04'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the fourth quarter and ful
Here's Why Veracyte (VCYT) is a Strong Growth Stock
10:46am, Wednesday, 04'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now
10:55am, Friday, 30'th Jan 2026
Veracyte (VCYT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tr
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Wednesday, 28'th Jan 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Veracyte, Inc. $VCYT Shares Purchased by Amalgamated Bank
03:08am, Tuesday, 27'th Jan 2026
Amalgamated Bank boosted its holdings in shares of Veracyte, Inc. (NASDAQ: VCYT) by 755.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission
Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again
01:10pm, Monday, 26'th Jan 2026
Veracyte (VCYT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term
10:50am, Thursday, 22'nd Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Oregon Public Employees Retirement Fund Takes $608,000 Position in Veracyte, Inc. $VCYT
05:36am, Monday, 19'th Jan 2026
Oregon Public Employees Retirement Fund bought a new position in Veracyte, Inc. (NASDAQ: VCYT) during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Veracyte: Profitable, De-Risked, And Ready To Run
09:44am, Friday, 16'th Jan 2026
Veracyte (VCYT) has transitioned to a profitable, diversified model with strong operating leverage and self-fortifying balance sheet. Key 2025-2026 catalysts include deeper prostate cancer penetration
Thermo Fisher Scientific (NYSE:TMO) & Veracyte (NASDAQ:VCYT) Financial Review
01:22am, Friday, 16'th Jan 2026
Veracyte (NASDAQ: VCYT - Get Free Report) and Thermo Fisher Scientific (NYSE: TMO - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesse
Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:16pm, Thursday, 15'th Jan 2026
Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
04:30pm, Sunday, 11'th Jan 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced preliminary, unaudited financial results for the fourth quarter and f
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference
04:30pm, Monday, 29'th Dec 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcar
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI
08:26am, Monday, 29'th Dec 2025
VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.
Analyzing Teleflex (NYSE:TFX) & Veracyte (NASDAQ:VCYT)
02:02am, Friday, 26'th Dec 2025
Teleflex (NYSE: TFX - Get Free Report) and Veracyte (NASDAQ: VCYT - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on t
